Is the new chikungunya vaccine safe for my young child?

A new vaccine is being developed specifically for children to protect them from chikungunya, a mosquito-borne virus that causes fever and joint pain. Researchers are currently running a large study to see if the vaccine is safe and effective for kids between the ages of 1 and 12. This trial compares the vaccine against a placebo to ensure the results are reliable.

What the research says

The primary goal of the ongoing study is to evaluate the safety of the CHIKV VLP vaccine in children aged 1 to 12 years ⁴. The researchers are looking for any adverse events, including serious ones, to determine if the vaccine causes harm ⁴. They are also measuring how well the vaccine triggers an immune response by checking for antibodies in the children's blood ⁴.

This safety evaluation is critical because chikungunya outbreaks are increasing in areas affected by climate change and urbanization, which can expand the habitats of the mosquitoes that carry the virus ¹. While specific clinical prediction models exist to identify chikungunya symptoms like arthritis and rash in children, preventing the infection through vaccination is a key control option being explored ¹².

The study is designed as a randomized, double-blind, placebo-controlled trial, which is the gold standard for proving a vaccine is safe before it is widely used ⁴. Enrollment for this trial is expected to reach 720 children, providing a robust dataset to assess risks ⁴.

What to ask your doctor

• Is my child eligible for the upcoming chikungunya vaccine trial or a similar approved vaccine?
• What are the common side effects reported in early studies of this vaccine?
• How does the risk of chikungunya in my area compare to the risk of vaccine side effects?
• Are there specific signs of chikungunya I should watch for if my child is exposed to mosquitoes?
• What other prevention methods, like mosquito nets or repellents, should we use while waiting for the vaccine results?